Earnings
NVAX
125.75
+22.56%
23.15
Currencies: USD
Items
Cash and Cash Equivalents
Short-term Investments
Short-term Securities
Accounts Receivable
Notes Receivable
Interest Receivable
Other Receivables
Prepayments
Inventories
Holding Assets for Sale
Unamortized Expenditures
Other Current Assets
Total Current Assets
Fixed Assets Net
Long-term Receivables
Long-term Investments
Deferred Tax Asset
Goodwill
Intangible Assets
Long-term Deferred Expenses
Other Non-current Assets
Total Non-current Assets
Total Assets
Short/Current Long Term Debt
Accounts Payable
Notes Payable
Taxes and Dues Payable
Salary Payable
Financing Expenses Payable
Other Payable
Advance Receipt
Accrued Expenses
Deferred Income
Holding Liabilities For Sale
Financial Derivative Liabilities
Other Current Liabilities
Total Current Liabilities
Long-term Debt
Long-term Payables
Long-term Deferred Income
Long-term Deferred Tax Liabilities
Other Non-current Liabilities
Total Non-current Liabilities
Total Liabilities
Common Stocks
Additional Paid-in Capital
Retained Earnings
Treasury Shares
Other Equity Instruments
Minority Interest
Equities Attributable to Parent Company
Total Equities
Total Liabilities and Equities
FY 2019-12-31
78.82M
0.00
--
7.50M
--
--
0.00
--
4.38M
--
--
6.55M
97.25M
17.90M
--
--
--
51.15M
5.58M
--
1.08M
75.71M
172.96M
--
2.91M
0.00
--
--
--
--
--
21.21M
--
--
--
1.68M
25.80M
320.61M
--
--
--
12.57M
333.18M
358.97M
324.00K
1.26B
-1.43B
-2.58M
--
--
-186.02M
-186.02M
172.96M
FY 2018-12-31
70.15M
21.98M
--
--
--
--
0.00
--
11.97M
--
--
15.17M
119.28M
28.43M
--
--
--
51.97M
6.54M
--
1.77M
88.70M
207.98M
--
9.30M
0.00
--
--
--
--
--
24.63M
--
--
--
11.61M
45.54M
319.19M
--
--
--
11.19M
330.37M
375.91M
3.85M
1.14B
-1.30B
-2.45M
--
--
-167.94M
-167.94M
207.98M
FY 2017-12-31
106.31M
51.00M
--
--
--
--
0.00
--
13.09M
--
--
32.92M
203.31M
35.99M
--
--
--
53.56M
7.87M
--
1.76M
99.18M
302.49M
--
5.61M
0.00
--
--
--
--
--
34.69M
--
--
--
33.37M
73.67M
317.76M
--
--
--
12.79M
330.55M
404.23M
3.24M
1.02B
-1.11B
-2.45M
--
--
-101.73M
-101.73M
302.49M
FY 2016-12-31
144.35M
91.13M
--
233.00K
--
--
0.00
--
15.74M
--
--
36.38M
287.83M
40.18M
--
--
--
51.67M
9.22M
--
5.39M
106.47M
394.30M
--
5.68M
0.00
--
--
--
--
--
29.59M
--
--
--
31.14M
66.41M
316.34M
--
--
--
17.10M
333.44M
399.85M
2.72M
936.00M
-930.00M
-2.45M
--
--
-5.55M
-5.55M
394.30M
FY 2015-12-31
93.11M
137.55M
--
2.32M
--
--
0.00
--
--
--
19.32M
34.96M
287.26M
32.34M
--
--
--
53.06M
10.79M
--
2.58M
98.78M
386.04M
--
11.89M
0.00
--
--
--
--
--
26.73M
--
--
--
37.48M
76.49M
0.00
--
--
--
16.88M
16.88M
93.37M
2.70M
951.57M
-650.03M
-2.45M
--
--
292.67M
292.67M
386.04M

FY: Financial Year. It represents annual report.

Q: Quarter Report. Q1、Q2、Q3、Q4 represent three-month periodic financial reports.

Check out NVAX latest quarterly and annual financial reports. There are also historical financial reports for you to reference. You can analyze Novavax recent business situations by check its income statements, balance sheets, cash flow statements and other tables. This information may help you make smarter investment decisions.